“Understanding the microbiome is the science of the future. We know that the microbiome runs on a circadian cycle and is affected by sleep. Every physician should be paying attention to and be aware of how the microbiome affects their area of medicine.” - Dr. Michael Breus
SAN FRANCISCO (PRWEB) May 14, 2018
uBiome, the leader in microbial genomics, announces the addition of Los Angeles-based sleep specialist, Dr. Michael Breus, to its Scientific Advisory Board - whose members include renowned scientists, doctors, and health experts from around the world. A clinical psychologist specializing in sleep disorders, Dr. Breus is a Diplomat of the American Board of Sleep Medicine and a Fellow of the American Academy of Sleep Medicine. His deep knowledge about sleep health will help uBiome accelerate its advancement in human microbiome research and further its mission to improve people’s lives.
“We are very pleased to welcome Dr. Breus to our Scientific Advisory Board,” said Dr. Jessica Richman, PhD, co-founder and CEO of uBiome. “His achievements in the highly specialized field of sleep medicine will prove to be an invaluable resource as we continue to expand our research about the meaningful connection between the human microbiome and sleep.”
An authority in his field, Dr. Breus is the author of three successful books concerning sleep health: “The Power of When,” “The Sleep Doctor's Diet Plan,” and “Beauty Sleep.” In addition, Dr. Breus writes for numerous blogs including The Insomnia Blog, The Huffington Post, Psychology Today, and was a contributing sleep expert at WebMD for 14 years. Dr. Breus is a talented public speaker and has given presentations to hundreds of Fortune 500 and Fortune 100 companies. To read more about Dr. Breus, visit The Sleep Doctor.
Dr. Breus, who has written articles on the relationship between gut health and sleep, said: “Understanding the microbiome is the science of the future. We know that the microbiome runs on a circadian cycle and is affected by sleep. Every physician should be paying attention to and be aware of how the microbiome affects their area of medicine.”
uBiome’s technology platform is based on the largest microbial dataset in the world (over 250,000 samples), covered by six issued patents (and over 100 pending applications), and used in over 20 peer-reviewed publications and presentations. This platform has been used by over 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, University of California, San Francisco, University College London, and University of Sydney.
In addition to Dr. Breus, the uBiome Scientific Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), and other leading scientists. The company’s Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children’s Hospital), as well as other accomplished clinicians.
Founded in 2012, uBiome is the world’s leading microbial genomics company with a mission to advance the science of the microbiome and make products that are useful. uBiome is funded by Y Combinator, Andreessen Horowitz, and 8VC, as well as other leading investors. Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018.